Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer

被引:1
作者
Hetzel, Jurgen [1 ,2 ]
Mauti, Laetitia A. A. [3 ]
Winkler, Jonas [4 ]
Almeida, Sabine Cardoso [3 ]
Jermann, Philip [5 ]
Pless, Miklos [3 ]
Bubendorf, Lukas [5 ]
Bode, Peter Karl [4 ]
Haentschel, Maik [1 ,2 ]
机构
[1] Eberhard Karls Univ Tubingen, Dept Med Oncol & Pneumol, D-72076 Tubingen, Germany
[2] Cantonal Hosp Winterthur, Dept Internal Med Pneumol, CH-8401 Winterthur, Switzerland
[3] Cantonal Hosp Winterthur, Dept Internal Med Med Oncol, CH-8401 Winterthur, Switzerland
[4] Cantonal Hosp Winterthur, Inst Pathol, CH-8401 Winterthur, Switzerland
[5] Univ Basel, Univ Hosp Basel, Inst Med Genet & Pathol, CH-4031 Basel, Switzerland
关键词
lung cancer; NSCLC; bronchoscopy; cryobiopsy; mediastinal lymph node biopsy; PEMBROLIZUMAB; CHEMOTHERAPY;
D O I
10.3390/jcm12062355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Personalized treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) requires detailed molecular characterization of the tumour including detection of predictive driver mutations and programmed death ligand 1 (PD-L1) expression. Complete detection is influenced by the amount of tumour cells sampled as well as their quality. Different sampling techniques may be necessary to provide sufficient tumour material for comprehensive molecular characterization. Missing the detection of targetable molecular genetic aberrations would have a serious impact on the quality of life and prognosis of a patient. This case report highlights the importance of biopsy technique in a patient with NSCLC. Several procedures-pleural puncture, transthoracic lung biopsy and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)-could not provide sufficient tumour material for precise tumour characterization. Only the addition of EBUS-guided transbronchial lymph node cryobiopsy (EBUS-TBLNC) enabled complete immunohistochemical and genetic tumour characterization, demonstrating PD-L1 expression in 100% of the tumour cells in the absence of actionable genetic alterations. Based on these results, immunotherapy was initiated.
引用
收藏
页数:4
相关论文
共 17 条
[1]   Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer [J].
Cicek, Tugba ;
Ozturk, Ayperi ;
Yilmaz, Aydin ;
Aktas, Zafer ;
Demirag, Funda ;
Akyurek, Nalan .
CLINICAL RESPIRATORY JOURNAL, 2019, 13 (02) :92-97
[2]   Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis [J].
Elias, Rawad ;
Giobbie-Hurder, Anita ;
McCleary, Nadine Jackson ;
Ott, Patrick ;
Hodi, F. Stephen ;
Rahma, Osama .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[3]   First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status [J].
Facchinetti, Francesco ;
Mazzaschi, Giulia ;
Barbieri, Fausto ;
Passiglia, Francesco ;
Mazzoni, Francesca ;
Berardi, Rossana ;
Proto, Claudia ;
Cecere, Fabiana Letizia ;
Pilotto, Sara ;
Scotti, Vieri ;
Rossi, Sabrina ;
Del Conte, Alessandro ;
Vita, Emanuele ;
Bennati, Chiara ;
Ardizzoni, Andrea ;
Cerea, Giulio ;
Migliorino, Maria Rita ;
Sala, Elisa ;
Camerini, Andrea ;
Bearz, Alessandra ;
De Carlo, Elisa ;
Zanelli, Francesca ;
Guaitoli, Giorgia ;
Garassino, Marina Chiara ;
Ciccone, Lucia Pia ;
Sartori, Giulia ;
Toschi, Luca ;
Dall'Olio, Filippo Gustavo ;
Landi, Lorenza ;
Pizzutilo, Elio Gregory ;
Bartoli, Gabriele ;
Baldessari, Cinzia ;
Novello, Silvia ;
Bria, Emilio ;
Cortinovis, Diego Luigi ;
Rossi, Giulio ;
Rossi, Antonio ;
Banna, Giuseppe Luigi ;
Camisa, Roberta ;
Di Maio, Massimo ;
Tiseo, Marcello .
EUROPEAN JOURNAL OF CANCER, 2020, 130 :155-167
[4]   Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments [J].
Genova, Carlo ;
Tagliabue, Elena ;
Mora, Marco ;
Aloe, Teresita ;
Dono, Mariella ;
Salvi, Sandra ;
Zullo, Lodovica ;
Barisione, Emanuela .
BMC PULMONARY MEDICINE, 2022, 22 (01)
[5]   Mediastinal "deep freeze"-transcarinal lymph node cryobiopsy [J].
Gershman, Evgeni ;
Amram Ikan, Alon ;
Pertzov, Barak ;
Rosengarten, Dror ;
Kramer, Mordechai Reuven .
THORACIC CANCER, 2022, 13 (11) :1592-1596
[6]  
Griesinger F., 2022, LUNGENKARZINOM NICHT
[7]   Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer [J].
Haentschel, Maik ;
Boeckeler, Michael ;
Ehab, Ahmed ;
Wagner, Robert ;
Spengler, Werner ;
Steger, Volker ;
Boesmueller, Hans ;
Horger, Marius ;
Lewis, Richard A. ;
Fend, Falko ;
Kanz, Lothar ;
Bonzheim, Irina ;
Hetzel, Juergen .
LUNG CANCER, 2020, 141 :56-63
[8]   Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies [J].
Nosaki, Kaname ;
Saka, Hideo ;
Hosomi, Yukio ;
Baas, Paul ;
de Castro, Gilberto, Jr. ;
Reck, Martin ;
Wu, Yi-Long ;
Brahmer, Julie R. ;
Felip, Enriqueta ;
Sawada, Takeshi ;
Noguchi, Kazuo ;
Han, Shi Rong ;
Piperdi, Bilal ;
Kush, Debra A. ;
Lopes, Gilberto .
LUNG CANCER, 2019, 135 :188-195
[9]   Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Planchard, D. ;
Popat, S. ;
Kerr, K. ;
Novello, S. ;
Smit, E. F. ;
Faivre-Finn, C. ;
Mok, T. S. ;
Reck, M. ;
Van Schil, P. E. ;
Hellmann, M. D. ;
Peters, S. .
ANNALS OF ONCOLOGY, 2018, 29 :192-237
[10]   Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC [J].
Ramalingam, S. S. ;
Vansteenkiste, J. ;
Planchard, D. ;
Cho, B. C. ;
Gray, J. E. ;
Ohe, Y. ;
Zhou, C. ;
Reungwetwattana, T. ;
Cheng, Y. ;
Chewaskulyong, B. ;
Shah, R. ;
Cobo, M. ;
Lee, K. H. ;
Cheema, P. ;
Tiseo, M. ;
John, T. ;
Lin, M-C ;
Imamura, F. ;
Kurata, T. ;
Todd, A. ;
Hodge, R. ;
Saggese, M. ;
Rukazenkov, Y. ;
Soria, J-C ;
Boyer, Michael ;
Lee, Chee ;
Hughes, Brett ;
O'Byrne, Kenneth ;
Briggs, Peter ;
Milward, Michael ;
John, Thomas ;
Demedts, Ingel ;
Vansteenkiste, Johan ;
Bustin, Frederique ;
Barrios, Carlos Henrique ;
Timcheva, Constanta ;
Butts, Charles ;
Goss, Glenwood ;
Juergens, Rosalyn ;
Leighl, Natasha ;
Cheng, Susanna ;
Burkes, Ronald ;
Zhou, Caicun ;
Zhang, Helong ;
Shu, Yongqian ;
Cheng, Ying ;
Zhou, Qing ;
Li, Wei ;
Feng, Guosheng ;
He, Yong .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :41-50